Lecong Hospital, Shunde District, Foshan
Lecong Hospital, Shunde District, Foshan
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC | Hepatocellular Carcinoma Non-resectable | Recruiting | Phase 3 | 2023-08-14 | NCT05985798 |